Pseudomonas aeruginosa (P. aeruginosa), an opportunistic bacterium is becoming increasingly antibiotic resistant. EU funding has applied a systems biology approach to identify genes involved in its survival with an eye on new drug therapies.
Healthcare settings are ideal for infections from antibiotic resistant microbes, with immune compromised patients and selection pressure applied by use of multiple antimicrobials. P. aeruginosa is a common cause of potentially fatal chronic infections such as sepsis and pneumonia due to its ability to form biofilms with its neighbours.
Further details: Systems biology applied to gut bacteria